These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 23116483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mono-PEGylated dimeric exendin-4 as high receptor binding and long-acting conjugates for type 2 anti-diabetes therapeutics.
    Kim TH, Jiang HH, Lee S, Youn YS, Park CW, Byun Y, Chen X, Lee KC.
    Bioconjug Chem; 2011 Apr 20; 22(4):625-32. PubMed ID: 21401109
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and evaluation of human serum albumin-modified exendin-4 conjugate via heterobifunctional polyethylene glycol linkage with protracted hypoglycemic efficacy.
    Kim I, Kim TH, Ma K, Lee ES, Kim D, Oh KT, Lee DH, Lee KC, Youn YS.
    Bioconjug Chem; 2010 Aug 18; 21(8):1513-9. PubMed ID: 20715855
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Trimeric PEG-Conjugated Exendin-4 for the Treatment of Sepsis.
    Lee W, Park EJ, Kwak S, Lee KC, Na DH, Bae JS.
    Biomacromolecules; 2016 Mar 14; 17(3):1160-9. PubMed ID: 26905040
    [Abstract] [Full Text] [Related]

  • 6. Preparation and evaluation of palmitic acid-conjugated exendin-4 with delayed absorption and prolonged circulation for longer hypoglycemia.
    Lee J, Lee C, Kim I, Moon HR, Kim TH, Oh KT, Lee ES, Lee KC, Youn YS.
    Int J Pharm; 2012 Mar 15; 424(1-2):50-7. PubMed ID: 22226877
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A 4-arm polyethylene glycol derivative conjugated with exendin-4 peptide and palmitylamine having dual-function of size-increase and albumin-binding for long hypoglycemic action.
    Kim I, Kim TH, Ma K, Park ES, Oh KT, Lee ES, Lee KC, Youn YS.
    Regul Pept; 2011 Apr 11; 167(2-3):239-45. PubMed ID: 21329731
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs.
    Chae SY, Jin CH, Shin JH, Son S, Kim TH, Lee S, Youn YS, Byun Y, Lee MS, Lee KC.
    J Control Release; 2010 Mar 03; 142(2):206-13. PubMed ID: 19900495
    [Abstract] [Full Text] [Related]

  • 11. Highly porous large poly(lactic-co-glycolic acid) microspheres adsorbed with palmityl-acylated exendin-4 as a long-acting inhalation system for treating diabetes.
    Kim H, Park H, Lee J, Kim TH, Lee ES, Oh KT, Lee KC, Youn YS.
    Biomaterials; 2011 Feb 03; 32(6):1685-93. PubMed ID: 21126761
    [Abstract] [Full Text] [Related]

  • 12. Decanoic acid-modified glycol chitosan hydrogels containing tightly adsorbed palmityl-acylated exendin-4 as a long-acting sustained-release anti-diabetic system.
    Lee C, Choi JS, Kim I, Byeon HJ, Kim TH, Oh KT, Lee ES, Lee KC, Youn YS.
    Acta Biomater; 2014 Feb 03; 10(2):812-20. PubMed ID: 24140611
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM, Eom HN, Jiang HH, Sohn M, Lee KC.
    J Pharm Sci; 2015 Jan 03; 104(1):72-80. PubMed ID: 25407390
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability.
    Youn YS, Chae SY, Lee S, Jeon JE, Shin HG, Lee KC.
    Biochem Pharmacol; 2007 Jan 01; 73(1):84-93. PubMed ID: 17054919
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects.
    Son S, Lim SM, Chae SY, Kim K, Park EJ, Lee KC, Na DH.
    Int J Pharm; 2015 Nov 10; 495(1):81-86. PubMed ID: 26325318
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.